Skip to content
PubMed This is a summary of 14 peer-reviewed journal articles Updated
Nephrology · Fanconi Renotubular Syndrome Type 2

Understanding Fanconi Renotubular Syndrome Type 2

At a Glance

Fanconi renotubular syndrome type 2 is a rare inherited kidney disorder caused by SLC34A1 changes. It makes the kidneys lose phosphate, leading to low blood phosphate and sometimes poor growth, dehydration, high calcium, or nephrocalcinosis; specialist monitoring is important.

Receiving a diagnosis of Fanconi Renotubular Syndrome Type 2 (FRTS2) often marks the end of a long period of uncertainty for families. Because it typically appears in infancy or early childhood, the diagnosis often follows symptoms like poor feeding, slow growth, or frequent dehydration [1][2]. It is a rare condition that requires a specialized approach, but understanding the underlying biology can help you partner more effectively with your medical team.

An Exceptionally Rare Condition

FRTS2 is an extremely rare genetic disorder. In medical literature, it is often documented only in small groups of patients or individual case reports [3]. Because of this rarity, it is common for local pediatricians or even general nephrologists (kidney specialists) to have never managed a case before.

This rarity often places parents in the role of medical advocate. You may find yourself explaining the condition to school nurses or other healthcare providers. This role is often described by caregivers as a “rollercoaster”—a mix of relief at having an answer and feeling overwhelmed by the complexity of the care required [4][5]. It is natural to feel a sense of grief, isolation, or exhaustion as you navigate a path that lacks a standard “roadmap” [6][7].

How the Condition Works

To understand FRTS2, it helps to think of the kidneys as a high-tech recycling center. The proximal tubule is a specific section of the kidney’s filtering unit responsible for “reclaiming” important nutrients like phosphate, glucose, and amino acids before they are lost in the urine [8].

In FRTS2, a genetic mutation in the SLC34A1 gene disrupts a specific transporter called NaPi-IIa [9]. This transporter acts like a specialized gate that pulls phosphate back into the bloodstream. When this gate doesn’t work:

  • Phosphate Wasting: The body cannot hold onto phosphate, leading to low levels in the blood (hypophosphatemia) [10].
  • Vitamin D Imbalance: The body may produce too much of the active form of Vitamin D (1,25-dihydroxyvitamin D), which can lead to high calcium levels in the blood (hypercalcemia) and urine (hypercalciuria) [11][1].
  • Proximal Tubular Dysfunction: Unlike broader forms of Fanconi syndrome, FRTS2 is primarily a phosphate-wasting disorder. Your doctor may check your urine for other substances like glucose or bicarbonate to rule out different diseases, but heavy losses of these are not typical expectations for FRTS2 [8].

Genetic, Not Acquired

It is important to distinguish FRTS2 from other forms of Fanconi syndrome. While some types can be “acquired”—meaning they are caused by exposure to certain medications, heavy metals, or toxins—FRTS2 is strictly inherited [12][8].

This means the condition was present from the moment of conception and was not caused by anything you did during pregnancy or any environmental exposure. Most often, it is inherited in an autosomal recessive pattern, meaning a child must inherit one pathogenic variant from each parent to show symptoms [1]. However, the specific way it affects a person can vary significantly even among family members with the same genetic markers [13].

What to Expect in Early Care

Because the kidneys are losing vital minerals, children often present with poor weight gain (failure to thrive) and polyuria (excessive urination) [1].

A core part of early management involves monitoring for nephrocalcinosis, which is the buildup of calcium deposits in the kidneys [11]. This is a common feature of the SLC34A1 mutation and is usually monitored via regular ultrasounds [3]. Your care team will likely focus on balancing electrolytes, ensuring proper hydration, and monitoring growth to minimize the impact on your child’s daily life [14][1].

Common questions in this guide

What causes Fanconi renotubular syndrome type 2?
FRTS2 is caused by a disease-causing change in the SLC34A1 gene. This change affects NaPi-IIa, a kidney transporter that normally helps return phosphate to the blood. The condition is inherited and is usually autosomal recessive; it is not caused by a parent's actions, a pregnancy exposure, or a toxin.
How is FRTS2 inherited?
Most cases follow an autosomal recessive pattern, meaning a child typically inherits one disease-causing SLC34A1 variant from each parent. The way the condition appears can vary, even among relatives with similar genetic findings. A genetic counselor can explain what one versus two variants may mean for the child and family.
What symptoms can FRTS2 cause in a child?
Possible signs include poor feeding, slow growth or poor weight gain, frequent dehydration, excessive urination, and unusual thirst. These signs can have many causes, so clinicians may use blood and urine tests, genetic results, and kidney ultrasound to assess a child. FRTS2 is rare, so consultation with a pediatric kidney specialist may be helpful.
Why does FRTS2 cause low phosphate and high calcium?
Healthy proximal tubules normally reclaim phosphate from the urine. In FRTS2, the SLC34A1-related NaPi-IIa transporter does not work properly, so phosphate is lost and blood phosphate may be low. The same disruption may increase active vitamin D, contributing to high calcium in the blood or urine.
How do doctors check for nephrocalcinosis?
Nephrocalcinosis is a buildup of calcium deposits in the kidneys. It is usually monitored with regular kidney ultrasounds, which can also help the care team look for kidney stones or other findings. Ask the clinician how often imaging is needed and what a result means for your child.
Is FRTS2 the same as acquired Fanconi syndrome?
No. FRTS2 is an inherited disorder in which phosphate wasting is the primary problem. Other forms of Fanconi syndrome can be acquired after exposure to certain medications, heavy metals, or toxins and may cause broader losses such as glucose or bicarbonate in the urine. Urine testing can help clinicians distinguish these conditions.
What does early care for FRTS2 involve?
Early care focuses on maintaining hydration, balancing electrolytes, monitoring growth, and checking for nephrocalcinosis. The care team can explain which signs of dehydration or high calcium to watch for at home and when to call for help. Because FRTS2 is rare, a pediatric nephrologist or specialist center may help coordinate care.

Get notified when new evidence is published on Fanconi renotubular syndrome 2.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

References

References (14)
  1. 1

    Presentation and outcome in carriers of pathogenic variants in SLC34A1 and SLC34A3 encoding sodium-phosphate transporter NPT 2a and 2c.

    Brunkhorst M, Brunkhorst L, Martens H, et al.

    Kidney international 2025; (107(1)):116-129 doi:10.1016/j.kint.2024.08.035.

    PMID: 39461557
  2. 2

    Autosomal-Recessive Mutations in SLC34A1 Encoding Sodium-Phosphate Cotransporter 2A Cause Idiopathic Infantile Hypercalcemia.

    Schlingmann KP, Ruminska J, Kaufmann M, et al.

    Journal of the American Society of Nephrology : JASN 2016; (27(2)):604-14 doi:10.1681/ASN.2014101025.

    PMID: 26047794
  3. 3

    Targeting Hypercalciuria in SLC34A1-Related Disorders: Impact of Oral Phosphate Therapy and Novel Genetic Insights in Pediatric Case Series.

    Turan I, Atar M, Eltan M, et al.

    Calcified tissue international 2026; (117(1)):10 doi:10.1007/s00223-025-01462-x.

    PMID: 41543768
  4. 4

    Emotional experience in parents of children with Zellweger spectrum disorders: A qualitative study.

    Bose M, Mahadevan M, Schules DR, et al.

    Molecular genetics and metabolism reports 2019; (19()):100459 doi:10.1016/j.ymgmr.2019.100459.

    PMID: 30815361
  5. 5

    Coping with the challenges of caregiving: A qualitative exploration of the experiences of family caregivers of children with rare diseases in South Africa.

    van Niekerk J, Gush M, Moosa S, Pretorius C

    Journal of genetic counseling 2026; (35(2)):e70205 doi:10.1002/jgc4.70205.

    PMID: 41958204
  6. 6

    The Lived Experience of Parents' Receiving the Diagnosis of CDKL5 Deficiency Disorder for Their Child.

    Demarest S, Marsh R, Treat L, et al.

    Journal of child neurology 2022; (37(6)):451-460 doi:10.1177/08830738221076285.

    PMID: 35196159
  7. 7

    Exploring the experiences of parents of children with Duchenne muscular dystrophy in Turkey: A descriptive phenomenological study.

    Bakir E, Arslanli SE

    Journal of pediatric nursing 2025; (82()):65-74 doi:10.1016/j.pedn.2025.02.015.

    PMID: 40048859
  8. 8

    Proximal renal tubular acidosis with and without Fanconi syndrome.

    Kashoor I, Batlle D

    Kidney research and clinical practice 2019; (38(3)):267-281 doi:10.23876/j.krcp.19.056.

    PMID: 31474092
  9. 9

    Inherited non-FGF23-mediated phosphaturic disorders: A kidney-centric review.

    Walker E, Hayes W, Bockenhauer D

    Best practice & research. Clinical endocrinology & metabolism 2024; (38(2)):101843 doi:10.1016/j.beem.2023.101843.

    PMID: 38042745
  10. 10

    Plasma intact fibroblast growth factor 23 level is a useful tool for diagnostic approach of renal hypophosphatemia.

    Giralt M, Chocron S, Ferrer R, Ariceta G

    Pediatric nephrology (Berlin, Germany) 2021; (36(4)):1025-1028 doi:10.1007/s00467-020-04906-8.

    PMID: 33492457
  11. 11

    Prenatal hyperechogenic kidneys in three cases of infantile hypercalcemia associated with SLC34A1 mutations.

    Hureaux M, Molin A, Jay N, et al.

    Pediatric nephrology (Berlin, Germany) 2018; (33(10)):1723-1729 doi:10.1007/s00467-018-3998-z.

    PMID: 29959532
  12. 12

    Inherited Fanconi syndrome.

    Albuquerque ALB, Dos Santos Borges R, Conegundes AF, et al.

    World journal of pediatrics : WJP 2023; (19(7)):619-634 doi:10.1007/s12519-023-00685-y.

    PMID: 36729281
  13. 13

    Experience with the targeted next-generation sequencing in the diagnosis of hereditary hypophosphatemic rickets.

    Turan I, Erdem S, Kotan LD, et al.

    Journal of pediatric endocrinology & metabolism : JPEM 2021; (34(5)):639-648 doi:10.1515/jpem-2020-0624.

    PMID: 33852231
  14. 14

    Inherited Fanconi renotubular syndromes: unveiling the intricacies of hypophosphatemic rickets/osteomalacia.

    Ragate DC, Memon SS, Karlekar M, et al.

    Journal of bone and mineral metabolism 2024; (42(2)):155-165 doi:10.1007/s00774-023-01490-3.

    PMID: 38310177

This page is for informational purposes only and does not constitute medical advice about Fanconi renotubular syndrome type 2. A pediatric nephrologist and genetics professional should interpret your child's results and guide hydration, electrolyte, growth, and ultrasound monitoring.